Related Experiment Video
Updated: May 15, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Operational challenges and solutions with implementation of an adaptive seamless phase 2/3 study
Kimberly Spencer1, Kelly Colvin, Brad Braunecker
1Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN 46285, USA. spencer_ka@lilly.com
Implementing a seamless phase 2/3 clinical trial for diabetes therapeutics requires significant upfront planning and cross-functional coordination. Operational challenges, including infrastructure flexibility and drug supply management, were addressed for successful trial execution.
Area of Science:
- Clinical trial design
- Pharmacology
- Diabetes therapeutics
Background:
- Adaptive trial designs offer efficiency but pose unique operational challenges.
- Seamless phase 2/3 trials integrate dose-finding and efficacy assessments.
- Diabetes therapeutics development requires robust trial methodologies.
Purpose of the Study:
- To detail the operational challenges encountered during the planning and implementation of an adaptive, dose-finding, seamless phase 2/3 trial for a diabetes therapeutic.
- To discuss resolutions for key operational hurdles in adaptive seamless trial designs.
Main Methods:
- Comparison of adaptive seamless design with conventional trial designs.
- Focus on upfront planning, cross-functional integration, and infrastructure adaptability.
- Emphasis on rapid data acquisition, analysis, and reporting for adaptive algorithms.
- Management of drug supply across multiple international sites for nine treatment arms.
Main Results:
- Significant upfront planning and enhanced cross-functional coordination were necessary.
- Existing infrastructure required modifications for flexibility to accommodate the adaptive design.
- Rapid data processes were critical for the adaptive algorithm's success.
- Complex drug supply logistics were managed across global sites.
Conclusions:
- Adaptive, seamless trial designs necessitate a proactive approach to operational planning.
- Flexibility in infrastructure and efficient data management are crucial for successful implementation.
- Careful management of drug supply is vital for multi-arm, global trials.
Related Concept Videos
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Bioavailability Study Design: Healthy Subjects Versus Patients
Preclinical Development: Overview
